Savara to Present at the Rodman & Renshaw 19th Annual Global Investment Conference on September 11th
AUSTIN, TX--(Marketwired - September 05, 2017) - Savara Inc. (NASDAQ: SVRA), a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare …